Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPVG.L Regulatory News (PVG)

  • There is currently no data for PVG

Blocklisting Interim Review

6 Dec 2013 17:46

RNS Number : 9748U
Ark Therapeutics Group PLC
06 December 2013
 



BLOCK LISTING SIX MONTHLY RETURN

 

Date: 6 December 2013

 

Name of applicant:

Ark Therapeutics Group plc

Name of scheme:

Ark Therapeutics Group Unapproved Share Option Scheme

Period of return:

From:

03/06/2013

To:

02/12/2013

Balance of unallotted securities under scheme from previous return:

2,271,252

Plus: The amount by which the block scheme has been increased since the date of the last return (if any increase has been applied for):

NIL

Less: Number of securities issued/allotted under scheme during period:

NIL

Equals: Balance under scheme not yet issued/allotted at end of period:

2,271,252

 

Name of applicant:

Ark Therapeutics Group plc

Name of scheme:

Ark Therapeutics Group Enterprise Management Incentive Share Option Plan

Period of return:

From:

03/06/2013

To:

02/12/2013

Balance of unallotted securities under scheme from previous return:

939,433

Plus: The amount by which the block scheme has been increased since the date of the last return (if any increase has been applied for):

NIL

Less: Number of securities issued/allotted under scheme during period:

NIL

Equals: Balance under scheme not yet issued/allotted at end of period:

939,433

 

Name of applicant:

Ark Therapeutics Group plc

Name of scheme:

Ark Therapeutics Group 2005 Long Term Incentive Plan

Period of return:

From:

03/06/2013

To:

02/12/2013

Balance of unallotted securities under scheme from previous return:

683,200

Plus: The amount by which the block scheme has been increased since the date of the last return (if any increase has been applied for):

NIL

Less: Number of securities issued/allotted under scheme during period:

NIL

Equals: Balance under scheme not yet issued/allotted at end of period:

683,200

 

Name of applicant:

Ark Therapeutics Group plc

Name of scheme:

Ark Therapeutics Group Approved Share Option Plan

Period of return:

From:

03/06/2013

To:

02/12/2013

Balance of unallotted securities under scheme from previous return:

1,000,000

Plus: The amount by which the block scheme has been increased since the date of the last return (if any increase has been applied for):

NIL

Less: Number of securities issued/allotted under scheme during period:

NIL

Equals: Balance under scheme not yet issued/allotted at end of period:

1,000,000

 

 

Name of contact:

Sue Steven, Company Secretary

Telephone number of contact:

0207 002 1005

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
BLRDMMGZNVDGFZM
Date   Source Headline
1st Mar 201310:50 amRNSForm 8.3 - [Ark Therapeutics]
26th Feb 20135:35 pmRNSHolding(s) in Company
26th Feb 20139:33 amRNSForm 8.3 - Ark Therapeutics Group PLC
25th Feb 201311:55 amRNSForm 8.3 - Ark Therapeutics Group PLC
25th Feb 201311:27 amRNSHolding(s) in Company
22nd Feb 20132:41 pmRNSHolding(s) in Company
21st Feb 20131:24 pmPRNForm 8.3 - Ark Therapeutics plc
21st Feb 201310:56 amRNSHolding(s) in Company
20th Feb 201312:54 pmPRNForm 8.3 - Ark Therapeutics plc
20th Feb 201312:11 pmRNSForm 8.3 - [Ark Therapeutics Group PLC]
19th Feb 20134:40 pmRNSSecond Price Monitoring Extn
19th Feb 20134:35 pmRNSPrice Monitoring Extension
15th Feb 201312:57 pmRNSForm 8.3 - Ark Therapeutics Group PLC
15th Feb 201310:39 amPRNForm 8.3 - Ark Therapeutics Group plc
12th Feb 201312:25 pmRNSHolding(s) in Company
7th Feb 20133:05 pmRNSHolding(s) in Company
7th Feb 20131:41 pmPRNForm 8.3 - Ark Therapeutics Group
6th Feb 20134:43 pmRNSForm 8.3 - Ark Therapeutics
6th Feb 201311:18 amPRNForm 8.3 - Ark Therapeutics Group
6th Feb 201311:02 amRNSForm 8 (OPD)
5th Feb 20134:35 pmRNSPrice Monitoring Extension
5th Feb 20132:48 pmRNSForm 8.3 - Ark Therapeutics Group PLC
4th Feb 20132:43 pmRNSForm 8.3 - Ark Therapeutics Group Plc
4th Feb 20131:10 pmRNSForm 8.3 - Ark Therapeutics
4th Feb 201310:11 amRNSForm 8.3 - [Ark Therapeutics]
1st Feb 20133:10 pmRNSForm 8.3 - Ark Therapeutics Group PLC
1st Feb 20132:53 pmRNSForm 8.3 - Ark Therapeutics Amendment
1st Feb 201312:41 pmRNSForm 8.3 - Ark Therapeutics Group plc
31st Jan 20133:42 pmRNSForm 8.3 - Ark Therapeutics Group PLC
31st Jan 20131:40 pmRNSForm 8.3 - Ark Therapeutics Group Plc
31st Jan 20131:31 pmRNSForm 8.3 - Ark Therapeutics Group plc
31st Jan 201312:02 pmRNSForm 8.3 - ARK Therapeutics plc
31st Jan 201311:51 amBUSForm 8.3 - Ark Therapeutics Group Plc
31st Jan 201311:14 amPRNForm 8.3 - Ark Therapeutics Group
30th Jan 20134:03 pmRNSForm 8.3 - Ark Therapeutics Group Plc
30th Jan 20137:00 amRNSStrategic Review Update
24th Jan 20133:33 pmRNSHolding(s) in Company
21st Jan 20137:00 amRNSCompany Update
4th Dec 20123:40 pmRNSBlocklisting Six Monthly Return
30th Nov 20127:00 amRNSFrench Tax Credit for Research and Development
8th Nov 20127:00 amRNSInterim Management Statement
15th Oct 20127:00 amRNSRe Agreement
26th Sep 20127:00 amRNSManufacturing Agreement Update
29th Aug 20127:00 amRNSHalf Yearly Report
24th Aug 20124:40 pmRNSSecond Price Monitoring Extn
24th Aug 20124:35 pmRNSPrice Monitoring Extension
14th Aug 20127:00 amRNSRe Agreement
25th Jul 20127:00 amRNSManufacturing Partnership
5th Jul 20127:00 amRNSDirectorate Change
11th Jun 20127:00 amRNSAppointment of New Head of Business Development

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.